Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 31.70
-0.25 (-0.78%)
Jul 30, 2026, 1:30 PM CST
Sinphar Pharmaceutical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,441 | 5,801 | 5,652 | 5,694 | 5,560 | 4,847 | |
Market Cap Growth | 13.25% | 2.64% | -0.75% | 2.41% | 14.71% | -6.62% |
Enterprise Value | 7,203 | 6,736 | 6,596 | 6,880 | 6,634 | 6,118 |
Last Close Price | 31.95 | 29.56 | 27.92 | 27.37 | 25.93 | 22.45 |
PE Ratio | 19.69 | 15.86 | 18.55 | 15.18 | 24.75 | - |
Forward PE | - | 16.95 | 17.05 | 62.19 | 62.19 | 62.19 |
PS Ratio | 1.90 | 1.72 | 1.79 | 1.92 | 1.95 | 1.99 |
PB Ratio | 1.69 | 1.56 | 1.59 | 1.68 | 1.73 | 1.58 |
P/TBV Ratio | 1.85 | 1.71 | 1.77 | 1.88 | 1.96 | 1.86 |
P/FCF Ratio | 17.32 | 14.88 | 16.01 | 6621.12 | 19.59 | - |
P/OCF Ratio | 10.11 | 9.92 | 9.52 | 19.21 | 13.07 | 35.76 |
EV/Sales Ratio | 2.12 | 2.00 | 2.09 | 2.32 | 2.32 | 2.51 |
EV/EBITDA Ratio | 11.24 | 10.20 | 12.22 | 13.28 | 14.85 | 95.71 |
EV/EBIT Ratio | 18.04 | 16.06 | 22.20 | 23.83 | 33.40 | - |
EV/FCF Ratio | 19.37 | 17.27 | 18.68 | 7999.47 | 23.38 | - |
Debt / Equity Ratio | 0.45 | 0.41 | 0.54 | 0.57 | 0.60 | 0.69 |
Debt / EBITDA Ratio | 2.65 | 2.28 | 3.52 | 3.75 | 4.28 | 33.06 |
Debt / FCF Ratio | 4.57 | 3.87 | 5.39 | 2261.46 | 6.74 | - |
Net Debt / Equity Ratio | 0.13 | 0.14 | 0.20 | 0.25 | 0.21 | 0.29 |
Net Debt / EBITDA Ratio | 0.77 | 0.78 | 1.34 | 1.67 | 1.50 | 13.91 |
Net Debt / FCF Ratio | 1.32 | 1.32 | 2.05 | 1004.31 | 2.36 | -83.59 |
Asset Turnover | 0.53 | 0.54 | 0.50 | 0.48 | 0.46 | 0.39 |
Inventory Turnover | 2.41 | 2.53 | 2.35 | 2.22 | 2.17 | 1.86 |
Quick Ratio | 1.66 | 1.72 | 1.30 | 1.46 | 1.36 | 1.22 |
Current Ratio | 2.37 | 2.50 | 1.84 | 2.20 | 1.92 | 1.76 |
Return on Equity (ROE) | 8.38% | 9.76% | 8.21% | 10.79% | 5.22% | -6.59% |
Return on Assets (ROA) | 3.92% | 4.21% | 2.96% | 2.90% | 2.00% | -1.85% |
Return on Invested Capital (ROIC) | 7.73% | 8.71% | 6.47% | 7.09% | 3.39% | -4.53% |
Return on Capital Employed (ROCE) | 7.60% | 8.20% | 6.10% | 5.70% | 4.20% | -3.90% |
Earnings Yield | 5.08% | 6.30% | 5.39% | 6.59% | 4.04% | -0.79% |
FCF Yield | 5.77% | 6.72% | 6.25% | 0.01% | 5.10% | -0.22% |
Dividend Yield | 2.96% | 3.38% | 3.41% | 3.22% | 3.40% | 0.79% |
Payout Ratio | 61.62% | 49.53% | 55.04% | 44.71% | 14.93% | - |
Buyback Yield / Dilution | -0.04% | -0.05% | -0.01% | 0.00% | -0.17% | - |
Total Shareholder Return | 2.92% | 3.33% | 3.40% | 3.23% | 3.23% | 0.79% |